High VCAM1 levels in tumor cells interact with osteoclast-expressed α4β1 integrin, which may recruit osteoclast precursor cells, initiate the osteoclast process, and ultimately induce the osteolytic clinical manifestations of bone metastasis (Lu et al., 2011). The gene discussed is VCAM1; the disease is neoplasm.